Uses amniotic membrane preserved with patented cryopreservation method to create a new generation of ocular surface tissue therapies designed to accelerate the regeneration of damaged tissue while reducing recipient discomfort associated with ocular surface reconstruction. Bio-Tissue offers the only commercially available amniotic membrane that preserves the native integrity, activity, and function exhibited by the tissue in utero for ocular surface wound repair and wound healing. Our proprietary processing and preservation method retains vital cytokines and growth factors which facilitate healing mechanisms such as: • Anti-inflammatory • Anti-scarring • Anti-angiogenic • Pain reduction • Promotion of epithelial healing
Looking for a particular Bio-Tissue employee's phone or email?
The Bio-Tissue annual revenue was $40.4 million in 2026.
Allen Hsu is the CIO of Bio-Tissue.
10 people are employed at Bio-Tissue.
Bio-Tissue is based in Miami, Florida.
The NAICS codes for Bio-Tissue are [33, 32, 541, 54, 3254, 32541, 325414, 325].
The SIC codes for Bio-Tissue are [873, 28, 87, 283].